BioCentury
ARTICLE | Company News

Biotie, Roche deal

November 1, 2010 7:00 AM UTC

Biotie and Roche mutually terminated a 2004 research and option deal to develop small molecule inhibitors of vascular adhesion protein-1 (VAP-1; SSAO) outside of Japan, Taiwan, Singapore, Australia a...